Clinical Trial Update: Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and activity of pertuzumab in advanced non-small cell lung cancer after prior chemotherapy; the study has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-06-08